Skip to main content
SpringerLink
Log in

Methodologic considerations in treatment using intraperitoneal chemotherapy

  • Chapter
Peritoneal Carcinomatosis: Principles of Management

Part of the book series: Cancer Treatment and Research ((CTAR,volume 82))

Abstract

Over the past decade several research groups have investigated the possible benefits of intraperitoneal chemotherapy in the management of intraabdominal cancers in both an adjuvant setting after resection for cure [1–10] and in an attempt to improve margins of excision following cytoreductive surgery [11–16]. Several important lessons may be learned from these clinical studies, which are relevant to a modern utilization of intraperitoneal chemotherapy. These observations should be used for further improvement of the methodology of chemotherapy delivery into the peritoneal cavity. These methodologic refinements may result in increased survival, alteration of a tumor’s natural history, and improved quality of life of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–237.

    Article  PubMed  CAS  Google Scholar 

  2. Fujimoto S, Shrestha R, Kokubun M, et al. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.

    Google Scholar 

  3. Kokubun M, Fujimoto S, Shrestha R, et al. Intraperitoneal hyperthermic perfusion treatment for patients with gastric cancer and peritoneal dissemination. Reg Cancer Treat 1991;3:316–319.

    Google Scholar 

  4. Schiessel R, Funovics J, Schick B, et al. Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: Results of a randomized trial. JAMA 1989;16: 68–69.

    CAS  Google Scholar 

  5. Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991;18:248–254.

    PubMed  CAS  Google Scholar 

  6. Markman M, Reichman B, Hakes T, et al. Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer. J Clin Oncol 1992;10:1479–1484.

    PubMed  CAS  Google Scholar 

  7. Atiq O, Kelsen D, Shiu M, et al. Phase II trial of prospective adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425–433.

    PubMed  CAS  Google Scholar 

  8. Leichman L, Silberman H, Leichman C, et al. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal chemotherapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 1992;10:1933–1942.

    PubMed  CAS  Google Scholar 

  9. Wansik Y, Sugarbaker P, Ilwoo W. Randomized controlled trial of early postoperative intraperitoneal chemotherapy in gastric cancer: A preliminary report. Reg Cancer Treat, 1994;2:90–93.

    Google Scholar 

  10. Sautner T, Hofbauer F, Depisch D, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long term survival after surgery for advanced gastric cancer. J Clin Oncol 1944;12:970–974.

    Google Scholar 

  11. Sugarbaker P, Graves T, DeBruijn E, et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–5794.

    PubMed  CAS  Google Scholar 

  12. Sugarbaker P, Zhu B, Banez Sese G, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery with intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323–329.

    Article  PubMed  CAS  Google Scholar 

  13. Sugarbaker P. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and Sarcomatosis. Dis Colon Rectum 1994;37(Suppl):S115-S122.

    Article  PubMed  CAS  Google Scholar 

  14. Yonemura Y, Fujimura T, Fushida S, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530–536.

    Article  PubMed  CAS  Google Scholar 

  15. Fujimoto S, Takahashi M, Okui K. A prospective study on combined treatment of intraperitoneal hyperthermic chemotherapy and surgery for patients with refractory gastric cancer. In Taguchi T, Aigner K, eds. Mitomycin C in Cancer Chemotherapy Today. Tokyo: Excerpta Medica, 1991, pp 105–118.

    Google Scholar 

  16. Markman M. Intraperitoneal chemotherapy in the treatment of ovarian cancer. J Infusion Chemother 1993;3:47–49.

    Google Scholar 

  17. Dedrick R. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985;12(Suppl 4):l-6.

    Google Scholar 

  18. Kerr D, Los G. Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 1993;17:105–122.

    PubMed  CAS  Google Scholar 

  19. Los G, Mutsaers P, Lenglet W, et al. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Phramcol 1990;25:389–394.

    Article  CAS  Google Scholar 

  20. Los G, Verdegaal E, Mutsaers P, McVie J. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 1991;28:159–165.

    Article  PubMed  CAS  Google Scholar 

  21. Panteix G, Guillaumont M, Cherpin L, et al. Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 1993;50:366–370.

    Article  PubMed  CAS  Google Scholar 

  22. Ozols R, Locker G, Doroshow J, et al. Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 1979;39:3209–3214.

    PubMed  CAS  Google Scholar 

  23. Menczer J, Ben-Baruch G, Rizel S, Brenner H. Intraperitoneal chemotherapy versus no treatment in patients with ovarian carcinoma who are in complete clinical remission. Cancer 1992;70:1956–1959.

    Article  PubMed  CAS  Google Scholar 

  24. Markman M, Jones W, Lewis J, et al. Impact of laparotomy finding of significant intra-adbominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy. Cancer Res Clin Oncol 1992;118:163–165.

    Article  CAS  Google Scholar 

  25. Markman M, Reichman B, Hakes T, et al. Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer 1993;71:1565–1570.

    Article  PubMed  CAS  Google Scholar 

  26. Osborne R. Future prospects for intraperitoneal therapy of cancer (editorial). Ann Oncol 1994;5:108–110.

    PubMed  CAS  Google Scholar 

  27. Markman M, Reichman M, Hakes T, et al. Responses to second-line cisplatin-based intraperitoneal chemotherapy in ovarian cancer: Influence of prior response to systemic cisplatin. J Clin Oncol 1991;9:1801–1805.

    PubMed  CAS  Google Scholar 

  28. Reichman B, Markman M, Hakes T, et al. Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma. J Clin Oncol 1989;7:1327–1332.

    PubMed  CAS  Google Scholar 

  29. Sugarbaker P, Jablonski K. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221(2):124–132.

    Article  PubMed  CAS  Google Scholar 

  30. Fernandez-Trigo V, Shamsa F, Sugarbaker P. Treatment failures after cytoreductive surgery and intraperitoneal chemotherapy in patients with pseudomyxoma. Acta Chir Austriaca 1995;27:79–83.

    Article  Google Scholar 

  31. Markman M, Hakes T, Reichman B, et al. Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: Influence of increasing the volume of treatment. Gynecol Oncol 1993;49: 185–189.

    Article  PubMed  CAS  Google Scholar 

  32. Esperanca M, Collins D. Peritoneal dialysis efficiency in relation to body weight. J Pediatr Surg 1966;1:162–169.

    Article  Google Scholar 

  33. Cromack D, Cromack T, Pretorius G, DeMeules J. Development of a predictive value equation for the minimum fluid volume to completely coat the intraperitoneal surface in rodents. Surg Forum 1985;36:477–478.

    Google Scholar 

  34. Dedrick R, Zahorko D, Binder R. Pharmacokinetic considerations on resistance to anticancer drugs. Cancer Chemother Rep 1975;59:795–478.

    PubMed  CAS  Google Scholar 

  35. Taylor A, et al. Loculation as a contraindication to intracavitary 32P-chromic phosphate therapy. J Nucl Med 1975;16:318–319.

    PubMed  Google Scholar 

  36. Vider M, DeLand F, Maruayama Y. Loculation as contraindication to 32P-chromic phosphate therapy. J Nucl Med 1976;17:150–151.

    PubMed  CAS  Google Scholar 

  37. Rosenhein N, Blake D, Mclntyre P, et al. The effect of volume on the distribution of substances instilled into the peritoneal cavity. Gynecol Oncol 1978;6:106–110.

    Article  Google Scholar 

  38. Wahl R, Gyves J, Gross B, et al. SPECT of the peritoneal cavity: Method for delineating intraperitoneal fluid distribution. AJR 1989;152:1205–1210.

    PubMed  CAS  Google Scholar 

  39. Myers M. Peritoneography. Normal and pathologic anatomy. Am J Roentgenol Radiat Ther Nucl Med 1973;117:353–365.

    Google Scholar 

  40. Dunnick N, Jones R, Doppman J, et al. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR 1979;1333:221–223.

    Google Scholar 

  41. Hughes P, Zammit-Maempel I, Murthy D, et al. Computed tomographic assessment of intraperitoneal fluid distribution prior to intraperitoneal chemotherapy for ovarian cancer. Br J Radiol 1992;65:295–297.

    Article  PubMed  CAS  Google Scholar 

  42. Giunta S, Tipaldi L, Diotellevi F, et al. CT demonstration of peritoneal metastases after intraperitoneal injection of contrast media. Clin Imaging 1990;14:31–34.

    Article  PubMed  CAS  Google Scholar 

  43. Rundback J, Gray R, Buck D, et al. Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy. JVIR 1994;5:161–165.

    Article  PubMed  CAS  Google Scholar 

  44. Barlogie B, Corry P, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-platinum and mitomycin C. Cancer Res 1980;40:1165–1168.

    PubMed  CAS  Google Scholar 

  45. Teicher B, Kowal C, Kennedy K, Sartorelli A. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41: 1096–1099.

    PubMed  CAS  Google Scholar 

  46. Wallner K, Li G. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin C and cisplatin. Cancer Res 1987;47:493–495.

    PubMed  CAS  Google Scholar 

  47. Koga S, Hamazoe R, Maeta M, et al. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984;44:1840–1842.

    PubMed  CAS  Google Scholar 

  48. Zoetmulder F. Modelstudies over het Colorectale Carcinoom. Rodopi, Amsterdam, 1982.

    Google Scholar 

  49. Murthy S, Goldsmith R, Rao L, et al. The influence of surgical trauma on experimental metastasis. Cancer 1989;64:2035–2044.

    Article  PubMed  CAS  Google Scholar 

  50. Sweitzer K, Nathanson S, Nelson L, Zashary C. Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. J Surg Oncol 1993;53:184–190.

    Article  PubMed  CAS  Google Scholar 

  51. Gunduz N, Fisher B, Saffer E. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–3865.

    PubMed  CAS  Google Scholar 

  52. Fisher B, Gunduz N, Saffer E. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–1492.

    PubMed  CAS  Google Scholar 

  53. Skipper D, Cooper A, Marston J, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049–1052.

    Article  PubMed  CAS  Google Scholar 

  54. Sugarbaker P. Recurrent and advanced primary colorectal cancer: Therapeutic implications of new concepts of gastrointestinal tumor biology. Baillieres Clin Gastroenterol 1989;3: Chapter 10.

    Google Scholar 

  55. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048–2052.

    Article  PubMed  CAS  Google Scholar 

  56. Jones A, Trott P, Cunningham D, et al. A pilot study of intraperitoneal cisplatin in the management of gastric cancer. Ann Oncol 1994;5:123–126.

    PubMed  CAS  Google Scholar 

  57. Fujimura T, Yonemura Y, Fushida S, et al. Continuous peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.

    Article  PubMed  CAS  Google Scholar 

  58. Shingleton W, Parker R, Mahaley S. Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery 1961;50:260–265.

    Google Scholar 

  59. Spratt J, Adcock R, Sherrill W, Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res 1980;40:253–255.

    PubMed  CAS  Google Scholar 

  60. Spratt J, Adcock R, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256–260.

    PubMed  CAS  Google Scholar 

  61. Fujimoto S, Shrestha R, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding: Ann Surg 1988;208:36–41.

    Article  PubMed  CAS  Google Scholar 

  62. Sugarbaker P. Intraperitoneal Chemotherapy and Cytoreductive Surgery. Manual for Physicians and Nurses. Grand Rapids, MI: Ludann, 1993.

    Google Scholar 

  63. Sugarbaker P. Abdomino-pelvic lavage apparatus and method. U.S. patent number 20531.

    Google Scholar 

  64. Fujimoto S, Takahashi M, Endoh F, et al. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer. Ann Surg 1991;213:43–47.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Andrew M. Averbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul H. Sugarbaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington Cancer Institute, 110 Irving Street, NW, Washington, DC, 20010, USA

    Paul H. Sugarbaker M.D., F.A.C.S.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Averbach, A.M., Sugarbaker, P.H. (1996). Methodologic considerations in treatment using intraperitoneal chemotherapy. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1247-5_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8531-1

  • Online ISBN: 978-1-4613-1247-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation